Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 3, 2013, Pages 367-371

  Baker, Jason V ^a,b   Hullsiek, Katherine Huppler ^c   Bradford, Robert L ^d   Prosser, Rachel ^b   Tracy, Russell P ^e,f   Key, Nigel S ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

Cardiovascular disease; Coagulation; HIV infection; Inflammation; Tissue factor activity

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; D DIMER; DARUNAVIR; INTERLEUKIN 6; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROCOAGULANT; PROTEINASE INHIBITOR; RALTEGRAVIR; TENOFOVIR DISOPROXIL; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; CD4 LYMPHOCYTE COUNT; FEMALE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; MIXED INFECTION; PRIORITY JOURNAL; SEROLOGY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; C-REACTIVE PROTEIN; CELL-DERIVED MICROPARTICLES; FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

EID: 84880202900     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182910121     Document Type: Article

References (27)

1. Neuhaus J, Angus B, Kowalska JD, et al. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24:697-706.
2. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010; 55:262-270.
3. Hunt P, Rodriguez B, Shive C, et al. Gut epithelial barrier dysfunction, inflammation, and coagulation predict higher mortality during treated HIV/AIDS. Presented at: 19th Conference on Retroviruses and Opportunistic Infections (CROI); March 5-8, 2012; Seattle, WA.
4. Musselwhite LW, Sheikh V, Norton TD, et al. Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. AIDS. 2011;25:787-795.
5. Ford ES, Greenwald JH, Richterman AG, et al. Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24:1509-1517.
6. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.
7. Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012;7: e44454.
8. Baker JV, Neuhaus J, Duprez D, et al. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. JAIDS. 2011;56:36-43.
9. Neuhaus J, Jacobs DR Jr, Baker JV, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201:1788-1795.
10. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost. 2010;36:865-875.
11. Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccha-ride. J Immunol. 1994;153:3245-3255.
12. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991; 83:356-362.
13. Baker J, Ayenew W, Quick H, et al. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis. 2010;201:285-292.
14. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6, C-reactive protein levels with mortality in the elderly. Am J Med. 1999; 106:506-512.
15. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51:268-273.
16. Tzoulaki I, Murray GD, Lee AJ, et al. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation. 2007;115: 2119-2127.
17. Stravitz RT, Bowling R, Bradford RL, et al. Role of procoagulant micro-particles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology. 2013 Feb 6. doi: 10.1002/hep.26307. [Epub ahead of print]
18. Lee RD, Barcel DA, Williams JC, et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res. 2012;129:80-85.
19. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet. 2007;370:1829-1839.
20. McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apo-lipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2008;372:224-233.
21. Funderburg NT, Mayne E, Sieg SF, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010;115:161-167.
22. Funderburg NT, Zidar DA, Shive C, et al. Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndromes. Blood. 2012;120:4599-4608.
23. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
24. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7:77-86.
25. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203: 780-790.
26. Paton NI; for the INSIGHT SMART Study Group. Association between activation of inflammatory and coagulation pathways and mortality during long-term follow-up in SMART. Presented at: 5th IAS Conference on HIV Pathogenesis Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
27. Folsom AR, Delaney JA, Lutsey PL, et al. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol. 2009;84:349-353.